Chung-Yu Huang
Overview
Explore the profile of Chung-Yu Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang A, Chen L, Tseng S, Huang C, Yen K, Chen L, et al.
J Nutr Health Aging
. 2024 Sep;
28(10):100359.
PMID: 39277970
Objectives: To develop an intrinsic capacity (IC) score and to investigate the association between IC transition with overall and cause-specific mortality, incident disability and healthcare utilization. Design: Retrospective cohort study...
2.
Huang C, Tan K, Huang S, Lu Y, Wang Y, Chen S, et al.
Discov Oncol
. 2024 Jul;
15(1):276.
PMID: 38981878
Hepatocellular carcinoma (HCC) is characterized by a notable sex disparity in incidence and tumor aggressiveness. Revealing differences in genetic landscapes between male and female HCCs may expand the understanding of...
3.
Chen P, Wei L, Huang C, Chang F, Lin Y
Int J Environ Res Public Health
. 2022 Oct;
19(20).
PMID: 36293771
Objective: To investigate the effect of force applied during massage on relieving nonspecific low back pain (LBP). Methods: This single-blinded, randomized controlled trial enrolled 56 female patients with nonspecific LBP...
4.
Chiang N, Tan K, Bai L, Hsiao C, Huang C, Hung Y, et al.
Clin Cancer Res
. 2022 Jul;
28(19):4248-4257.
PMID: 35849151
Purpose: Modified gemcitabine and S-1 (GS) is an active regimen for patients with advanced biliary tract cancer (ABTC) in our previous study. Herein, we report the results of a single-arm...
5.
Huang C, Cheng C, Chiou W, Chang W, Kang Y, Lee M
J Ethnopharmacol
. 2021 Oct;
283:114732.
PMID: 34637967
Ethnopharmacological Relevance: Duhuo Jisheng Decoction (DHJSD) is the most frequently prescribed herbal formula for the treatment of osteoporosis. However, efficacy and safety of DHJSD add-on bisphosphonate medications remain unclear. Aim...
6.
Kuo T, Hsu S, Huang S, Chang C, Feng C, Huang M, et al.
EMBO Mol Med
. 2021 Sep;
13(10):e11668.
PMID: 34542937
Loss of β-cell number and function is a hallmark of diabetes. β-cell preservation is emerging as a promising strategy to treat and reverse diabetes. Here, we first found that Pdia4...
7.
Yeh K, Yeh T, Huang C, Hu C, Wang M, Huang Y, et al.
Life Sci
. 2021 May;
278:119574.
PMID: 33961850
Aims: Dipeptidyl peptidase 4 (DPP-4) is a valid molecular drug target from which its inhibitors have been developed as medicines for treating diabetes. The present study evaluated a new synthetic...
8.
Chen L, Hwang A, Huang C, Chen L, Wang F, Chan Y
Immun Ageing
. 2021 May;
18(1):21.
PMID: 33947427
Background: Chronic infections played a detrimental role on health outcomes in the aged population, and had complex associations with lymphocyte subsets distribution. Our study aimed to explore the predictive roles...
9.
Hsu L, Soong T, Chu N, Huang C, Kao S, Lin Y
J Clin Med
. 2020 Dec;
9(12).
PMID: 33322487
Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it fails. We hypothesize that the therapy-induced inflammatory responses inhibit the cancer progression, and...
10.
Chen Y, Lo C, Chiu T, Hsu C, Yeh T, Chen C, et al.
Transl Oncol
. 2020 Oct;
14(1):100897.
PMID: 33069101
Zinc(II)-dipicolylamine (Zn-DPA) has been shown to specifically identify and bind to phosphatidylserine (PS), which exists in bulk in the tumor microenvironment. BPRDP056, a Zn-DPA-SN38 conjugate was designed to provide PS-targeted...